Envestnet Asset Management Inc. reduced its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 4.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 174,094 shares of the semiconductor company’s stock after selling 7,605 shares during the quarter. Envestnet Asset Management Inc. owned 0.11% of Synopsys worth $84,498,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently added to or reduced their stakes in the company. Kieckhefer Group LLC acquired a new stake in shares of Synopsys in the 4th quarter worth approximately $27,000. Whipplewood Advisors LLC acquired a new stake in Synopsys in the fourth quarter valued at $33,000. Pilgrim Partners Asia Pte Ltd acquired a new position in shares of Synopsys during the 4th quarter worth $34,000. Sierra Ocean LLC purchased a new stake in shares of Synopsys in the 4th quarter worth about $39,000. Finally, Hazlett Burt & Watson Inc. grew its stake in Synopsys by 28.6% in the 4th quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company’s stock valued at $44,000 after acquiring an additional 20 shares during the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.
Synopsys Stock Up 0.2 %
NASDAQ:SNPS opened at $381.59 on Wednesday. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $624.80. The firm’s 50 day moving average is $465.72 and its two-hundred day moving average is $500.48. The company has a market cap of $59.00 billion, a P/E ratio of 26.28, a P/E/G ratio of 3.23 and a beta of 1.23.
Insider Buying and Selling
Analyst Ratings Changes
Several analysts have issued reports on the stock. Rosenblatt Securities reaffirmed a “buy” rating and issued a $660.00 price target on shares of Synopsys in a report on Tuesday, February 25th. Morgan Stanley reduced their target price on Synopsys from $625.00 to $590.00 and set an “overweight” rating on the stock in a research note on Monday, February 24th. Redburn Atlantic initiated coverage on Synopsys in a research report on Monday, January 13th. They set a “buy” rating and a $600.00 price target for the company. Wells Fargo & Company reduced their price objective on Synopsys from $540.00 to $520.00 and set an “equal weight” rating on the stock in a research report on Thursday, February 27th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $650.00 price objective on shares of Synopsys in a research note on Thursday, February 27th. One research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat.com, Synopsys currently has an average rating of “Moderate Buy” and a consensus target price of $638.58.
Check Out Our Latest Analysis on Synopsys
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
- Five stocks we like better than Synopsys
- How to Short Nasdaq: An Easy-to-Follow Guide
- Tariff-Proof Stocks: 3 Big Bargains With Huge Upside Potential
- How to Use the MarketBeat Stock Screener
- Qualcomm Breaks Down But RSI Signals It’s Severely Oversold
- Ride Out The Recession With These Dividend Kings
- Tesla’s #1 Bull Cuts Target But Says It’s Still a Buy
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.